Skip to content
healthcare.dev
Get a free key

VARIZIG

NDC 49591-126, HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN, injection, solution, from Kamada Ltd..

Product NDC
49591-126
Status
Listed
Labeler
Kamada Ltd.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125430
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49591-126 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN125 [iU]/1.2mL
Package NDCNDC-11Package
49591-126-51495910126511 VIAL, GLASS in 1 CARTON (49591-126-51) / 1.2 mL in 1 VIAL, GLASS (49591-126-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49591-126 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49591-126 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49591-126. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.